| Accession |
PRJCA003177 |
| Title |
Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma |
| Relevance |
Medical |
| Data types |
Epigenomics
|
| Organisms |
Homo sapiens
|
| Description |
Here, we sought to develop a reliable liquid biopsy model using 5-hydroxymethylcytosine (5hmC) signatures of plasma cell-free DNA (cfDNA) and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma (HCC). |
| Sample scope |
Multiisolate |
| Release date |
2021-07-23 |
| Data provider |
| Data provider |
Data provider URL |
| Frontier Science Center for Disease Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University |
http://www.wchscu.cn/index.html |
|
|
| Biomaterial provider |
The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| National Science and Technology Major Project of China
|
|
2018ZX10302205
|
|
| Regional development project of Fujian province
|
|
2019Y3001
|
|
| National Natural Science Foundation of China
|
|
31771426
|
|
| the Scientific Foundation of the Fuzhou Health Commission
|
|
2019Swt3
|
|
|
|
| Submitter |
Dan
Xie (danxie@scu.edu.cn)
|
| Organization |
West China Hospital Sichuan University |
| Submission date |
2020-08-04 |
